BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24301461)

  • 21. Predicting early cancer-related deaths after curative esophagectomy for esophageal cancer.
    Matsumoto S; Takayama T; Wakatsuki K; Enomoto K; Tanaka T; Migita K; Ito M; Nakajima Y
    Am Surg; 2013 May; 79(5):528-33. PubMed ID: 23635590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer.
    Merkow RP; Bilimoria KY; Keswani RN; Chung J; Sherman KL; Knab LM; Posner MC; Bentrem DJ
    J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 25031273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.
    Lotan Y; Bagrodia A; Passoni N; Rachakonda V; Kapur P; Arriaga Y; Bolenz C; Margulis V; Raj GV; Sagalowsky AI; Shariat SF
    Eur Urol; 2013 Sep; 64(3):465-71. PubMed ID: 23571005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extent of Lymphadenectomy and Prognosis After Esophageal Cancer Surgery.
    Lagergren J; Mattsson F; Zylstra J; Chang F; Gossage J; Mason R; Lagergren P; Davies A
    JAMA Surg; 2016 Jan; 151(1):32-9. PubMed ID: 26331431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A reliable risk score for stage IV esophagogastric cancer.
    Blank S; Lordick F; Dobritz M; Grenacher L; Burian M; Langer R; Roth W; Schaible A; Becker K; Bläker H; Sisic L; Stange A; Compani P; Schulze-Bergkamen H; Jäger D; Büchler M; Siewert JR; Ott K
    Eur J Surg Oncol; 2013 Aug; 39(8):823-30. PubMed ID: 23375470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cause of death during long-term follow-up for superficial esophageal adenocarcinoma.
    Kauppi J; Gockel I; Rantanen T; Hansen T; Ristimäki A; Lang H; Sihvo E; Räsänen J; Junginger T; Salo JA
    Ann Surg Oncol; 2013 Jul; 20(7):2428-33. PubMed ID: 23354564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
    Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J
    Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and benefit of curative surgical resection for esophageal squamous cell cancer associated with multiple primary cancers.
    Otowa Y; Nakamura T; Takiguchi G; Yamamoto M; Kanaji S; Imanishi T; Oshikiri T; Suzuki S; Tanaka K; Kakeji Y
    Eur J Surg Oncol; 2016 Mar; 42(3):407-11. PubMed ID: 26733367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoscopic tumor length is an independent prognostic factor in esophageal squamous cell carcinoma.
    Wang BY; Liu CY; Lin CH; Hsu PK; Hsu WH; Wu YC; Cheng CY
    Ann Surg Oncol; 2012 Jul; 19(7):2149-58. PubMed ID: 22407313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of positive transection margins with gastric cancer survival and local recurrence.
    Bickenbach KA; Gonen M; Strong V; Brennan MF; Coit DG
    Ann Surg Oncol; 2013 Aug; 20(8):2663-8. PubMed ID: 23536054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influence of number of removed lymph nodes on the TNM staging and survival in advanced esophageal carcinoma].
    Chen LQ; Hu CY; Zhang HL; He M; Meng XL; Ping YM
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):604-8. PubMed ID: 18210881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical Management of Early-Stage Esophageal Adenocarcinoma Based on Lymph Node Metastasis Risk.
    Newton AD; Predina JD; Xia L; Roses RE; Karakousis GC; Dempsey DT; Williams NN; Kucharczuk JC; Singhal S
    Ann Surg Oncol; 2018 Jan; 25(1):318-325. PubMed ID: 29147928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Esophageal cancer in Iran; a population-based study regarding adequacy of cancer surgery and overall survival.
    Harirchi I; Kolahdoozan S; Hajizadeh S; Safari F; Sedighi Z; Nahvijou A; Mir MR; Mousavi SM; Zendehdel K
    Eur J Surg Oncol; 2014 Mar; 40(3):352-7. PubMed ID: 24238763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of prognosis after trimodal therapy in patients with locally advanced squamous cell carcinoma of the oesophagus.
    Stahl M; Lehmann N; Walz MK; Stuschke M; Wilke H
    Eur J Cancer; 2012 Nov; 48(16):2977-82. PubMed ID: 22503151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Positive Margins on Survival in Patients Undergoing Esophagogastrectomy for Esophageal Cancer.
    Javidfar J; Speicher PJ; Hartwig MG; D'Amico TA; Berry MF
    Ann Thorac Surg; 2016 Mar; 101(3):1060-7. PubMed ID: 26576752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postoperative surveillance and prognostic factors in patients with esophageal cancer.
    Kunisaki C; Makino H; Kimura J; Ota M; Takagawa R; Kosaka T; Ono HA; Akiyama H; Endo I
    Hepatogastroenterology; 2014; 61(133):1262-73. PubMed ID: 25436294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.
    Zhang HD; Tang P; Duan XF; Chen CG; Ma Z; Gao YY; Zhang H; Yu ZT
    J Surg Oncol; 2013 Dec; 108(8):542-9. PubMed ID: 24018956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.